Company news
Abattis Bioceuticals Corp (OTC:ATTBF) news
Abattis Bioceuticals Corp news releases on 6ix. Latest, Feb 13, 2018: Abattis Looks to Leverage Crypto for Cannabis M&A -- CFN Media
Press releases — page 2
Abattis Looks to Leverage Crypto for Cannabis M&A -- CFN Media
February 13, 2018
Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia
February 12, 2018
Abattis Completes Investment in CannaNUMUS Blockchain and Announces CannaNUMUS’s Achievement of a Significant Milestone
February 8, 2018
Abattis Enters Into Definitive Agreement to Acquire 49% Stake In CannaNUMUS Blockchain
February 1, 2018
Abattis Announces Successful Completion of Acquisition of Green Tree Therapeutics
January 25, 2018
Abattis Enters Cannabinoid-Infused Beverages Market in a Big Way -- CFN Media
January 23, 2018
Abattis Partners with Vancouver-Based Craft Brewer to Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer
January 22, 2018
Abattis Enters Into Definitive Agreement to Acquire Green Tree Therapeutics
January 11, 2018
Abattis Announces LOI for Partnership with Alliance of Beverage Licensees
January 9, 2018
Abattis Provides Company Update and Comments on LOI Regarding Green Tree Therapeutics
December 22, 2017
Abattis Announces Expansion of Northern Vine Dealer’s License
December 18, 2017
Northern Vine Labs Expands Dealer’s License with Health Canada
December 15, 2017
Abattis Confirms Breakthrough Extraction Technology Capabilities
December 12, 2017
Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media
November 22, 2017
Abattis Announces Completion of Investment by Emerald Health Therapeutics in Northern Vine
November 21, 2017
Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine
November 21, 2017
CFN Media Exclusive CEO Interview: Abattis Validates Lab Strategy, Sets Stage for Rapid Growth
November 6, 2017
Abattis Announces Strategic Investment into Northern Vine and Partnership with Emerald Health Therapeutics
October 26, 2017
Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine
October 26, 2017
Abattis Offers a Solution to Canada's Cannabis Pesticide Problem -- CFN Media
October 17, 2017
For Early Success in Cannabis Look Outside the Box
October 11, 2017
Abattis signs definitive distribution agreement with GD Pharma to sell Abattis products in South Korea
October 3, 2017
Abattis regains 100% ownership in Northern Vine to focus and expand on Lab and Extraction strategy
September 26, 2017
Abattis Prepares for Growth in Extracts -- CFN Media
September 20, 2017
Abattis provides important update on Northern Vine and Sales Division
September 13, 2017
Abattis Looks to Become a Go-To for LPs to Diversify -- CFN Media
August 31, 2017
Abattis Announces Breakthrough CBD-Based Sunscreen Formulation
August 28, 2017
Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets
August 23, 2017
Abattis Announces Receipt of Cultivation License by LP Partner
August 21, 2017
Canada's Plans for Near-term Legalization Puts Testing into Focus -- CFN Media
April 6, 2017
Abattis Addresses Key Shortcomings in Canada's Cannabis Industry -- CFN Media
February 9, 2017
Abattis Explores Diversifying with a Strategic Acquisition -- CFN Media
January 19, 2017
Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules -- CFN Media
January 5, 2017
Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media
November 28, 2016
Abattis' Federally Licensed Lab and the Crucial Role It Plays -- CFN Media
November 2, 2016
Abattis (ATTBF): A Leader in Canada's Cannabis Testing Industry -- CFN Media
October 18, 2016
OTC Markets Group Welcomes Newly Verified OTCQB Companies – March 1
March 1, 2016
Abattis Selects Ingredient Identity as Global Regulatory Management Partner
May 11, 2015
Abattis Appoints Hugh Oswald as Investor Relations
May 1, 2015
Abattis Bioceuticals Investor Update for Q2 2015
April 28, 2015
Abattis CEO Roadshow
April 20, 2015
Affinor Growers and Abattis Bioceuticals Corp. Amicably Resolve Washington Litigation and Agree to Dismiss the Case With Prejudice
April 10, 2015
Abattis Information to Be Available in S&P Capital IQ Market Access Program
March 25, 2015
S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports
March 25, 2015
Abattis Announces Private Placement
March 9, 2015
Baby Boomers Spend Billions to Stay Young
March 9, 2015
Abattis, BioCell Product Launch at CannaCon and Update
February 17, 2015
Abattis Retains J2 Response as a Marketing Partner
February 10, 2015
BioCell Labs Initiates Product Development
February 10, 2015
Abattis Enters Into US$25 Million Equity Line Facility Agreement with Dutchess Opportunity Fund, II, LP
February 4, 2015